http://www.whale.to/v/autism3.html
How
many people have autistic spectrum disorders?
How many people have autism?" is one of the most frequent questions
asked and unfortunately it is also one of the most difficult to answer. There
is no central register of everyone who has autism- which means that any
information about the possible number of people with autism in the community
must be based on epidemiological surveys (i.e. studies of distinct and
identifiable populations).
It is more than 50 years since Leo Kanner first described his classic
autistic syndrome. Since then, the results of research and clinical work have
led to the broadening of the concept of autistic disorders. In consequence,
estimates of prevalence have increased considerably. This process has occurred
in stages, the start of each of which can be linked to particular studies. The
history is summarised and the most up to date figures are given below and in
Tables 1 and 2 overleaf.
Kanner
Syndrome
1943
The specific pattern of abnormal behaviour first described by Leo Kanner is
also known as ‘early infantile autism’. Kanner made no estimate of the possible
numbers of people with this condition but he thought that it was rare (Kanner
1943).
Over twenty years later, Victor Lotter published the first results of an
epidemiological study of children with the behaviour pattern described by
Kanner in the former county of Middlesex, which gave an overall prevalence rate
of 4.5 per 10,000 children (Lotter 1966).
The
Triad of Impairments in Children with Learning Disabilities
1979
In 1979 Lorna Wing and Judith Gould examined the prevalence of autism, as
defined by Leo Kanner, among children known to have special needs in the former
London Borough of Camberwell. They found a prevalence in those with IQ under 70
of nearly 5 per 10,000 for this syndrome, closely similar to the rate found by
Lotter. However, as well as looking at children with Kanner autism, Wing &
Gould also identified a larger group of children (about 15 per 10,000) who had
impairments of social interaction, communication and imagination (which they
referred to as the ‘triad’ of impairments), together with a repetitive
stereotyped pattern of activities. Although these children did not fit into the
full picture of early childhood autism (or typical autism) as described by
Kanner they were identified as being within the broader ‘autistic spectrum’.
Thus, the total prevalence rate for the spectrum in all children with special
needs in the Camberwell study was found to be approximately 20 in every 10,000
children (Wing & Gould 1979). Gillberg et al (1986) in Gothenburg, Sweden,
found very similar rates in children with learning disabilities.
There have been a number of other epidemiological studies in different
countries examining the prevalence of autism (but not the whole spectrum).
These results range from 3.3 to 16.0 per 10,000, possibly due to differences in
definitions or case-finding methods (Wing, 1993).
Asperger
Syndrome
The studies described above identified autistic disorders in children the
great majority of whom had learning disabilities and special educational needs.
However, in 1944, Hans Asperger in Vienna had published an account of children
with many similarities to Kanner autism but who had abilities, including
grammatical language, in the average or superior range. There are continuing
arguments concerning the exact relationship between Asperger and Kanner
syndromes but it is beyond dispute that they have in common the triad of
impairments of social interaction, communication and imagination and a narrow,
repetitive pattern of activities (Wing, 1981; 1991).
1993
In 1993, Stephan Ehlers and Christopher Gillberg published the results of a
further study carried out in Gothenburg in which they examined children in
mainstream schools in order to find the prevalence of Asperger syndrome and
other autistic spectrum disorders in children with IQ of 70 or above. From the
numbers of children they identified they calculated a rate of 36 per 10,000 for
those who definitely had Asperger syndrome and another 35 per 10,000 for those
with social impairments. Some of the latter may have fitted Asperger
description if more information had been available, but they certainly had
disorders within the autistic spectrum. The children who were identified were
known by their teachers to be having social and/or educational problems but the
nature of their difficulties had not been recognised prior to the study.
1995
For over 30 years, Sula Wolff, in Edinburgh, has studied children of average
or high ability who are impaired in their social interaction but who do not
have the full picture of the triad of impairments. In her book giving results
of her studies (Wolff, 1995), she emphasises that the clinical picture overlaps
with Asperger syndrome to a large extent. However, these children represent the
most subtle and most able end of the autistic spectrum. The majority become
independent as adults, many marry and some display exceptional gifts, though
retaining the unusual quality of their social interactions.
Why include them in the autistic spectrum? As Sula Wolff points out, they
often have a difficult time at school and they need recognition, understanding
and acceptance from their parents and teachers. The approach that suits them
best is the same as that which is recommended for children with Asperger
syndrome and high functioning autism.
In her discussion of prevalence, Sula Wolff quotes Ehlers and Gillberg’s
study. She considers that their total figure of 71 per 10,000, includes the
children she describes.
Estimated
Prevalence Rates in the UK
Table 1
|
People with Learning Disabilities Approximate Rates per 10,000 (IQ under
70) |
Approximate Rates per 10,000 |
|
Kanner Syndrome |
5 |
|
Other spectrum disorders |
15 |
|
Total |
20 |
|
People with average or high ability (IQ 70 or above) |
|
|
Asperger syndrome |
36 |
|
Other spectrum disorders |
35 |
|
Total |
71 |
|
Possible total prevalence rate of all autistic spectrum disorders |
91 |
The
Autistic Population
It is possible that there are real differences in prevalence of autistic
spectrum disorders in different parts of the world, even in different parts of the
same country, and at different times. An epidemic of encephalitis, for example,
could increase the number of affected children. However, it is very likely that
some, even most, of the variation is due to differences of definitions and the
difficulty of defining the borderlines of sub-groups within the whole autistic
spectrum (Wing, 1996). There are no sharp boundaries separating ‘typical’
autism from other autistic disorders, including Asperger syndrome. [For a
complete overview of the problems of establishing prevalence rates and the
difficulties of diagnosing and defining autism, see Wing 1 993].
The best estimates of the total prevalence of autistic spectrum disorders
are those based on the Camberwell and Gothenburg studies, because these focused
on the whole spectrum and not just specific sub-groups:
Estimated
Population of Autistic Spectrum Disorders in the UK
Table 2
|
People with Learning Disabilities (lQ under 70) (Note 1: Almost all of these
people will need care and supervision all their lives.) |
||
|
|
Kanner’s |
Other Spectrum Disorders |
|
Children |
5,200 |
21,000 |
|
Adults |
17,700 |
71,100 |
|
AllAges |
22,900 |
92,100 |
|
Total
115,000 |
||
|
People with Average or High
Ability (lQ 70 or above). (Note 2: Many, perhaps most of these people,
will become semi or fully independent as adults but need understanding and
help as children.) |
||
|
|
Asperger Syndrome |
Other Spectrum Disorders |
|
Children |
47,400 |
46,000 |
|
Adults |
160,100 |
150,000 |
|
All Ages |
207,500 |
196,000 |
|
Total
403,500 |
||
Ref: National Autistic society
ALL
INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR
GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE
KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED
AS PROVIDING MEDICAL OR LEGAL ADVICE. THE DECISION WHETHER OR NOT TO
VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU
ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.